Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection—What Do We Know, and What More Do We Need to Know? | Zendy

Charles L. Bennett | Zendy; Terhi Hermanson | Zendy

Open Access

Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection—What Do We Know, and What More Do We Need to Know?

Author(s) -

Charles L. Bennett,

Terhi Hermanson

Publication year - 2015

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.08060715

Subject(s) - medicine , hemodialysis , intravenous iron , anemia , kidney disease , dialysis , intensive care medicine , exacerbation , cohort study , emergency medicine , iron deficiency

When treating patients with CKD on hemodialysis with active infection, a key tenet is do no harm. CKD is a major public health problem that consumes a disproportionate and increasing share of health care resources. Treating CKD was estimated to cost Medicare $44.6 billion in 2014, although there is

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research